to the editor. It is important to realize that only novel observations about a single case will be considered. The editorial policy of the journal is to render a decision about each submission within 24 hours of the authors completing the submission. Our intention is to allow authors to submit their work to another journal as rapidly as possible. One or two editors read the submission and decide to start the quality assurance process for consideration of publication or reject the work without rendering comments. If the manuscript fails the quality assurance process, then the manuscript may be rejected. One such example is when the authors of an Original Investigation did not obtain institutional review board approval and/or did not register the study with clinicaltrials.gov or an equivalent site; then the manuscript cannot be considered. Another goal of JAMA Dermatology is to use social media to inform physicians and the public about dermatologic advances in the recognition and treatment of diseases. Ashish Bhatia, MD, the Web and Social Media Editor, leads this initiative with weekly releases on Twitter and Facebook. JAMA Dermatology currently has 14 280 Twitter followers. The quiz cases published in the Clinicopathological Challenge section under the direction of the Section Editor, Molly Hinshaw, MD, with the support of the Assistant Section Editors Soon